Effect of a combination of donepezil tablets and butylphthalide soft capsules on neurological function in dementia patients, and its effect on serum inflammatory factors

  • Fuqiang Ma
  • Tao Chen
  • Yanqiu Wang
  • Junxia Xu
Keywords: Vascular dementia, Donepezil tablets, Butylphthalide soft capsules, Neurological function, Inflammatory factors

Abstract

Purpose: To determine the effect of combined use of donepezil tablets and butylphthalide soft capsules in the treatment of patients with vascular dementia, and its effect on serum inflammatory factor levels and neurological functional recovery of patients.
Methods: 120 patients with vascular dementia were selected and assigned to group A (n = 60) and group B (n = 60). All patients were treated with donepezil tablets, while patients in group A were, in addition, treated with butylphthalide soft capsules. Mini mental state examination (MMSE) scores, clinical dementia rating scale (CDRS) scores, activities of daily living (ADL) scores, incidence of adverse reactions, serum inflammatory factor levels and neurological functional recovery were determined.
Results: There was significantly higher MMSE score in group A than in B, while CDRS score was lower in group A. The ADL scores and inflammatory factor levels were lower in group A than in B (p < 0.001), while neurological functional recovery was markedly better in A (p < 0.001). Incidents of unwanted events were comparable in groups A and B, and there were no serious complications in the patients.
Conclusion: The combination therapy of donepezil tablets and butylphthalide soft capsules reduces inflammatory factor levels and improved cognitive level and quality of life of patients with vascular dementia. It also produces good neurological functional recovery and low incidence of adverse reactions. Therefore, this treatment strategy has potentials for the management of vascular dementia.

Published
2022-04-28
Section
Articles

Journal Identifiers


eISSN: 1596-9827
print ISSN: 1596-5996